FDA Inspection 1076077 — CMIC Pharma Science Co., Ltd.
The FDA completed an inspection of CMIC Pharma Science Co., Ltd. on Dec 5, 2018 in Ishikari. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ishikari (Japan)